Skip to main content

Niagen Bioscience, Inc. (NAGE) Stock Forecast 2025 - AI Price Prediction & Analysis


Niagen Bioscience, Inc. (NAGE) AI Stock Price Forecast & Investment Analysis

Niagen Bioscience, Inc. Stock Price Chart and Technical Analysis

Loading Niagen Bioscience, Inc. interactive price chart and technical analysis...

Niagen Bioscience, Inc. (NAGE) - Comprehensive Stock Analysis & Investment Research

Deep dive into Niagen Bioscience, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Niagen Bioscience, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Niagen Bioscience, Inc.: Niagen Bioscience, Inc. operates in the Life Sciences sector, making it an emerging small-cap investment.

Niagen Bioscience, Inc. (Stock Symbol: NAGE) is a leading company in the Life Sciences sector , specifically operating within the Medicinal Chemicals & Botanical Products industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Niagen Bioscience, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Niagen Bioscience, Inc.: With $116M in annual revenue, the company demonstrates developing profitability.

Annual Revenue: $116 million .

Market Capitalization: $799 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Niagen Bioscience, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Niagen Bioscience, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Niagen Bioscience, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Niagen Bioscience, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Niagen Bioscience, Inc.: Market positioning analysis based on available financial and operational metrics.

Niagen Bioscience, Inc. strategically competes in the highly dynamic Medicinal Chemicals & Botanical Products marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Niagen Bioscience, Inc. (NAGE) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Niagen Bioscience, Inc. stock analysis.

Loading Niagen Bioscience, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Niagen Bioscience, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Niagen Bioscience, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Niagen Bioscience, Inc.: With a P/E ratio of 45.05, the market highly values future growth prospects.

P/E Ratio 45.05x
P/B Ratio 12.44x
Market Cap $799M
EPS $0.23
Book Value/Share $0.76
Revenue/Share $1.37
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Niagen Bioscience, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Niagen Bioscience, Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Niagen Bioscience, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Niagen Bioscience, Inc.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Niagen Bioscience, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Niagen Bioscience, Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Niagen Bioscience, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Niagen Bioscience, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Niagen Bioscience, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Niagen Bioscience, Inc.: With annual revenue of $116M, Niagen Bioscience, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $116M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 85M

Latest Niagen Bioscience, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Niagen Bioscience, Inc. (NAGE) stock price and investment outlook.

, source: Yahoo Finance

As the Nasdaq hits new record highs and the Federal Reserve's anticipated interest rate decision looms, investors are keeping a close eye on market movements. In this environment, growth companies ...

Niagen Bioscience, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Niagen Bioscience, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAWH Unlock Forecast - 30 Days FREE Trial $153M x 5.6x
AIBT Unlock Forecast - 30 Days FREE Trial $0M x x
AYRWF Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BTMD Unlock Forecast - 30 Days FREE Trial $388M 15.7x -3.0x
CBDY Unlock Forecast - 30 Days FREE Trial $1M x x
CDXC Unlock Forecast - 30 Days FREE Trial $536M -666.2x 11.6x
CGC Unlock Forecast - 30 Days FREE Trial $202M -0.3x 0.4x
CRON Unlock Forecast - 30 Days FREE Trial $1015M 54.9x 0.9x
CURLF Unlock Forecast - 30 Days FREE Trial $2189M x 2.5x
CXXIF Unlock Forecast - 30 Days FREE Trial $41M x 1.4x
CYAN Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.3x
FTLF Unlock Forecast - 30 Days FREE Trial $120M 19.3x 3.1x
GHBWF Unlock Forecast - 30 Days FREE Trial $37M x 0.3x
GLASF Unlock Forecast - 30 Days FREE Trial $811M x 7.0x
GLUC Unlock Forecast - 30 Days FREE Trial $0M x x
JUSHF Unlock Forecast - 30 Days FREE Trial $141M x x
MNMD Unlock Forecast - 30 Days FREE Trial $803M -3.1x 4.3x
MTEX Unlock Forecast - 30 Days FREE Trial $18M -55.4x 2.4x
NAGE Unlock Forecast - 30 Days FREE Trial $799M 45.1x 12.4x
NAII Unlock Forecast - 30 Days FREE Trial $26M -3.3x 0.3x
RAJAF Unlock Forecast - 30 Days FREE Trial $1020M x x
RAPH Unlock Forecast - 30 Days FREE Trial $4M x x
SMFL Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
SNYR Unlock Forecast - 30 Days FREE Trial $33M -551.3x -2.1x
TCNNF Unlock Forecast - 30 Days FREE Trial $1304M x 1.1x
TCRG Unlock Forecast - 30 Days FREE Trial $16M x x
TLRY Unlock Forecast - 30 Days FREE Trial $684M -4.1x 0.3x
UPXI Unlock Forecast - 30 Days FREE Trial $279M -10.6x 150.7x
USNA Unlock Forecast - 30 Days FREE Trial $570M 13.6x 1.1x

Frequently Asked Questions - Niagen Bioscience, Inc. Stock Forecast

How accurate are Niagen Bioscience, Inc. stock predictions?

Our AI model demonstrates 55% historical accuracy for NAGE predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Niagen Bioscience, Inc. stock price forecasts?

Our analysis considers Niagen Bioscience, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Niagen Bioscience, Inc. a good investment in 2025?

Based on our AI analysis, Niagen Bioscience, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Niagen Bioscience, Inc. forecasts updated?

Niagen Bioscience, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Niagen Bioscience, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Niagen Bioscience, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...